Hikma Pharmaceutical | HIK - Capital Ordinaire

Prix De L'Action
1,322.00
Variation Quotidienne
-4.50 -0.34%
Mensuellement
8.81%
Annuel
-27.76%
Q2 Prévisions
1,297.41




Capital Ordinaire Changement Date
Almirall EUR 214.79M 0 2025-12
AstraZeneca USD 1.55B 206K 2025-12
Autolus Therapeutics Ltd USD 266.14M 1.88K 2025-09
Bayer EUR 982.42M 0 2025-12
Fresenius EUR 563.24M 0 2025-09
Galapagos EUR 65.9M 0 2025-12
Genmab DKK 61.62M 52K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
GRIFOLS EUR 680.58M 846K 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 68.64M 0 2025-12
Merck EUR 434.78M 0 2025-12
Orion EUR 140.69M 0 2025-09
Recordati EUR 205.83M 270K 2025-09
Roche Holding CHF 795.62M 699.54K 2025-12
UCB EUR 190.36M 365.15K 2025-12